-

HCA Healthcare Names Cynthia Cifuentes-Finkel Senior Vice President of Marketing and Corporate Affairs

NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare (NYSE: HCA) today announced that Cynthia Cifuentes-Finkel has been named senior vice president of marketing and corporate affairs, effective June 8, 2026. She will report to Mike McAlevey, executive vice president, chief legal and administrative officer, and will lead enterprise marketing, corporate communications, and stakeholder engagement in support of HCA Healthcare’s enterprise growth priorities.

“Cynthia is a strategic and accomplished leader with deep experience building trusted brands, strengthening reputation and aligning communications with organizational strategic imperatives,” said McAlevey. “She brings a strong track record of leading high-performing teams, navigating complex operating environments and advancing meaningful engagement with key stakeholders in support of the organization’s growth and long-term strategic priorities. We are pleased to welcome Cynthia to HCA Healthcare and are confident her leadership will help further strengthen our brand, our corporate stakeholder engagement and our overall impact.”

Cifuentes-Finkel brings over 25 years of executive leadership experience across healthcare, consumer marketing and global media. With 15 years in successive senior leadership roles at Kaiser Permanente, she most recently served as regional vice president of communications and strategic partnerships for Southern California and Hawaii – the organization’s largest division serving nearly 5 million patients.

Throughout her career, she has enhanced brand and stakeholder strategies, driving enterprise growth and transformative community investments in multiple markets. She also led the advancement of new models of care through innovative clinical partnerships and AI integration.

Cifuentes-Finkel holds an MBA from Mount St. Mary’s University and a bachelor’s degree in journalism from the University of Nevada, Las Vegas. She serves on the boards of the Strathmore Arts Center and the Latino Student Fund in Washington, D.C. and is an Executive Fellow of The Economic Club of Washington, D.C.

She succeeds Deb Reiner, who recently retired after more than 25 years of distinguished service and leadership contributions to HCA Healthcare.

“Deb has played a vital role in creating HCA Healthcare’s branding and corporate affairs strategy,” said McAlevey. “Her leadership and commitment have helped advance our organization and support the work of our colleagues across the enterprise. We wish her all the best in her retirement.”

About HCA Healthcare
Nashville-based HCA Healthcare is one of the nation’s leading providers of healthcare services, comprising 189 hospitals and approximately 2,600 ambulatory sites of care, including surgery centers, freestanding ERs, urgent care centers, and physician clinics, in 19 states and the United Kingdom. With its founding in 1968, HCA Healthcare created a new model for hospital care in the United States, using combined resources to strengthen hospitals, deliver patient-focused care and improve the practice of medicine. HCA Healthcare has conducted a number of clinical studies, including one that demonstrated that full-term delivery is healthier than early elective delivery of babies and another that identified a clinical protocol that can reduce bloodstream infections in ICU patients by 44%. HCA Healthcare is a learning health system that uses its approximately 47 million annual patient encounters to advance science, improve patient care and save lives.

All references to “Company,” “HCA” and “HCA Healthcare” as used throughout this document refer to HCA Healthcare, Inc. and its affiliates.

Contacts

INVESTOR CONTACT:
Frank Morgan
615-344-2688

MEDIA CONTACT:
Harlow Sumerford
615-344-1851

HCA Healthcare

NYSE:HCA

Release Versions

Contacts

INVESTOR CONTACT:
Frank Morgan
615-344-2688

MEDIA CONTACT:
Harlow Sumerford
615-344-1851

More News From HCA Healthcare

HCA Healthcare Reports Third Quarter 2026 Results

NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the third quarter ended September 30, 2026. Key third quarter metrics (all percentage changes compare 3Q 2026 to 3Q 2025 unless otherwise noted): Revenues increased 3.6 percent to $19.849 billion Net income attributable to HCA Healthcare, Inc. declined 3.9 percent to $1.579 billion Diluted earnings per share increased 4.5 percent to $7.27 per diluted share, and diluted earning...

HCA Healthcare to Host Eighth Annual “Crush the Crisis” National Prescription Drug Take Back Day

NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE:HCA), one of the nation’s leading healthcare providers, today announced it will host its eighth annual “Crush the Crisis” national prescription drug take back day. On Saturday, Oct. 24, 2026, HCA Healthcare facilities from across the country will partner with local law enforcement to help patients, families and communities safely and anonymously dispose of unused or expired medications at more than 130 collection sites, helping keep...

HCA Healthcare, Inc. 3rd Quarter 2026 Earnings Conference Call

NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) announces the following Webcast: What: HCA Healthcare, Inc. 3Q 2026 Earnings Call When: Tuesday, October 27, 2026, at 9:00 AM Central (10:00 AM Eastern) How: Live Audio over the Internet: https://investor.hcahealthcare.com/events-and-presentations/default.aspx Contact: Frank Morgan, 615-344-2688, Vice President, Investor Relations, frank.morgan@hcahealthcare.com If you are unable to listen during the live webcast, the call will...
Back to Newsroom